(3S)-pyrrolidin-3-ol → 6-[8-((S)-3-hydroxy-pyrrolidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrazin-2-ylamino]-3,3-dimethyl-1,3-dihydro-indol-2-one
反応式
[OH:1][C@@H:2]1[CH2:6][CH2:5][N:4]([C:7]2[C:8]3[N:9]([N:13]=[C:14]([NH:16][C:17]4[CH:25]=[C:24]5[C:20]([C:21]([CH3:28])([CH3:27])[C:22](=[O:26])[NH:23]5)=[CH:19][CH:18]=4)[N:15]=3)[CH:10]=[CH:11][N:12]=2)[CH2:3]1.O[C@H]1CCNC1>>[OH:1][C@H:2]1[CH2:6][CH2:5][N:4]([C:7]2[C:8]3[N:9]([N:13]=[C:14]([NH:16][C:17]4[CH:25]=[C:24]5[C:20]([C:21]([CH3:28])([CH3:27])[C:22](=[O:26])[NH:23]5)=[CH:19][CH:18]=4)[N:15]=3)[CH:10]=[CH:11][N:12]=2)[CH2:3]1参加物
3
実験手順
The compound is synthesized using the procedure described for 6-[8-((R)-3-hydroxy-pyrrolidin-1-yl)-[1,2,4]triazolo[1,5-a]pyrazin-2-ylamino]-3,3-dimethyl-1,3-dihydro-indol-2-one with (S)-3-hydroxy-pyrrolidin as nuceophile.
後処理
- customThe compound is synthesized
出典と根拠
- ORDレコード
- ord-652cb10cdb7048938dc35bc373606f12
- 出典データセット
- uspto-grants-2015_09
- 特許番号
- US09120804B2
反応ノート
読み込み中…